- Report
- February 2026
- 200 Pages
Global
From €2667EUR$2,990USD£2,287GBP
- Report
- January 2026
- 129 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- May 2026
- 139 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- August 2026
- 293 Pages
Global
From €2230EUR$2,500USD£1,913GBP
- Report
- September 2026
- 192 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- September 2026
- 369 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- July 2026
- 115 Pages
Global
From €4237EUR$4,750USD£3,634GBP
- Report
- June 2026
- 200 Pages
North America
From €2667EUR$2,990USD£2,287GBP
- Report
- November 2025
- 338 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- November 2025
- 150 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- September 2025
- 145 Pages
Global
From €4326EUR$4,850USD£3,710GBP
- Report
- November 2025
- 150 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- January 2026
- 180 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- September 2026
- 191 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- September 2026
- 180 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP

The Autoimmune Disease Diagnostics market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of autoimmune diseases. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Diagnostics for autoimmune diseases involve a variety of tests, such as blood tests, imaging tests, and biopsies. These tests are used to identify the presence of antibodies, which are proteins produced by the immune system in response to an autoimmune disease.
The Autoimmune Disease Diagnostics market is driven by the increasing prevalence of autoimmune diseases, as well as advances in technology that have enabled more accurate and efficient diagnosis. Additionally, the increasing availability of diagnostic tests has made them more accessible to patients.
Some companies in the Autoimmune Disease Diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, and Siemens Healthineers. Show Less Read more